• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌的起源细胞:来自小鼠研究的启示。

Cells of origin of lung cancers: lessons from mouse studies.

机构信息

Division of Molecular Genetics, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA.

出版信息

Genes Dev. 2020 Aug 1;34(15-16):1017-1032. doi: 10.1101/gad.338228.120.

DOI:10.1101/gad.338228.120
PMID:32747478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7397855/
Abstract

As one of the most common forms of cancer, lung cancers present as a collection of different histological subtypes. These subtypes are characterized by distinct sets of driver mutations and phenotypic appearance, and they often show varying degrees of heterogenicity, aggressiveness, and response/resistance to therapy. Intriguingly, lung cancers are also capable of showing features of multiple subtypes or converting from one subtype to another. The intertumoral and intratumoral heterogeneity of lung cancers as well as incidences of subtype transdifferentiation raise the question of to what extent the tumor characteristics are dictated by the cell of origin rather than the acquired driver lesions. We provide here an overview of the studies in experimental mouse models that try to address this question. These studies convincingly show that both the cell of origin and the genetic driver lesions play a critical role in shaping the phenotypes of lung tumors. However, they also illustrate that there is far from a direct one-to-one relationship between the cell of origin and the cancer subtype, as most epithelial cells can be reprogrammed toward diverse lung cancer fates when exposed to the appropriate set of driver mutations.

摘要

作为最常见的癌症类型之一,肺癌表现为多种不同的组织学亚型。这些亚型的特征是具有不同的驱动突变和表型表现,并且它们通常表现出不同程度的异质性、侵袭性以及对治疗的反应/耐药性。有趣的是,肺癌还具有表现出多种亚型特征或从一种亚型转化为另一种亚型的能力。肺癌的肿瘤间和肿瘤内异质性以及亚型转化的发生率提出了一个问题,即肿瘤特征在多大程度上是由起源细胞决定的,而不是由获得的驱动病变决定的。我们在这里提供了一个实验小鼠模型研究的概述,这些研究试图解决这个问题。这些研究令人信服地表明,起源细胞和遗传驱动病变都在塑造肺癌肿瘤的表型方面起着关键作用。然而,它们也说明了起源细胞和癌症亚型之间远非直接的一一对应关系,因为大多数上皮细胞在暴露于适当的驱动突变集时可以被重新编程为多种肺癌命运。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/ef2542b4cac1/1017f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/670bb81303da/1017f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/e04401454a40/1017f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/d33be5e97751/1017f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/ef2542b4cac1/1017f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/670bb81303da/1017f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/e04401454a40/1017f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/d33be5e97751/1017f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb23/7397855/ef2542b4cac1/1017f04.jpg

相似文献

1
Cells of origin of lung cancers: lessons from mouse studies.肺癌的起源细胞:来自小鼠研究的启示。
Genes Dev. 2020 Aug 1;34(15-16):1017-1032. doi: 10.1101/gad.338228.120.
2
Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologies.腺癌之外:鳞状细胞癌、小细胞癌及罕见组织学类型肺癌的当前治疗方法与未来方向
Am Soc Clin Oncol Educ Book. 2015:147-62. doi: 10.14694/EdBook_AM.2015.35.147.
3
Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.在条件重编程培养条件下培养的切除非小细胞肺癌标本中,非恶性呼吸道上皮细胞优先增殖。
Oncotarget. 2017 Feb 14;8(7):11114-11126. doi: 10.18632/oncotarget.14366.
4
Mechanisms involved in lung cancer development in COPD.COPD 中肺癌发生的相关机制。
Int J Biochem Cell Biol. 2011 Jul;43(7):1030-44. doi: 10.1016/j.biocel.2010.08.022. Epub 2010 Oct 14.
5
Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO).按组织学类型划分的二手烟草烟雾暴露与肺癌:国际肺癌研究协会(ILCCO)的汇总分析
Int J Cancer. 2014 Oct 15;135(8):1918-30. doi: 10.1002/ijc.28835. Epub 2014 Mar 25.
6
Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies.吸烟与肺癌——病例对照研究荟萃分析的主要组织学类型的相对风险估计。
Int J Cancer. 2012 Sep 1;131(5):1210-9. doi: 10.1002/ijc.27339. Epub 2011 Dec 14.
7
Different Originating Cells Underlie Intertumoral Heterogeneity in Lung Neuroendocrine Tumors.不同起源细胞构成肺神经内分泌肿瘤的肿瘤间异质性。
Cancer Discov. 2018 Oct;8(10):1216-1218. doi: 10.1158/2159-8290.CD-18-0979.
8
Mouse models of lung squamous cell carcinomas.肺鳞癌的小鼠模型。
Cancer Metastasis Rev. 2013 Jun;32(1-2):77-82. doi: 10.1007/s10555-012-9406-4.
9
Smoking attenuates transforming growth factor-β-mediated tumor suppression function through downregulation of Smad3 in lung cancer.吸烟通过下调肺癌中 Smad3 来减弱转化生长因子-β介导的肿瘤抑制功能。
Cancer Prev Res (Phila). 2012 Mar;5(3):453-63. doi: 10.1158/1940-6207.CAPR-11-0313. Epub 2012 Jan 9.
10
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.通过多区域组织和配对 ctDNA 测序比较非小细胞肺癌不同亚型的肿瘤内异质性。
Mol Cancer. 2019 Jan 9;18(1):7. doi: 10.1186/s12943-019-0939-9.

引用本文的文献

1
Molecular Characteristics, Heterogeneity, Plasticity, and Cell of Origin of Neuroendocrine Bladder Cancer.神经内分泌膀胱癌的分子特征、异质性、可塑性及起源细胞
Cancer Heterog Plast. 2025;2(1). doi: 10.47248/chp2502010005. Epub 2025 Mar 6.
2
Tracing the evolution of single-cell 3D genomes in Kras-driven cancers.追踪Kras驱动的癌症中单细胞3D基因组的演变。
Nat Genet. 2025 Aug 18. doi: 10.1038/s41588-025-02297-w.
3
Non-coding RNAs and Hippo signaling in non-small cell lung cancer: emerging roles as biomarkers and therapeutic targets.

本文引用的文献

1
Investigating Tumor Heterogeneity in Mouse Models.在小鼠模型中研究肿瘤异质性。
Annu Rev Cancer Biol. 2020 Mar;4(1):99-119. doi: 10.1146/annurev-cancerbio-030419-033413. Epub 2019 Nov 6.
2
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.MYC 通过重编程神经内分泌命运驱动小细胞肺癌亚型的时间演变。
Cancer Cell. 2020 Jul 13;38(1):60-78.e12. doi: 10.1016/j.ccell.2020.05.001. Epub 2020 May 30.
3
FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
非编码RNA与非小细胞肺癌中的Hippo信号通路:作为生物标志物和治疗靶点的新作用
Discov Oncol. 2025 Jul 18;16(1):1365. doi: 10.1007/s12672-025-03099-6.
4
Complementary modes of resistance to TKI in lung adenocarcinoma through MAPK activation and cellular plasticity.通过丝裂原活化蛋白激酶(MAPK)激活和细胞可塑性对肺癌腺癌中酪氨酸激酶抑制剂(TKI)产生的互补性耐药模式。
bioRxiv. 2025 May 10:2025.05.07.652714. doi: 10.1101/2025.05.07.652714.
5
SLC34A2 inhibits tumorigenesis and progression via upregulating LRRK2/TTF-1/SELENBP1 axis in lung adenocarcinoma.SLC34A2通过上调肺腺癌中的LRRK2/TTF-1/SELENBP1轴来抑制肿瘤发生和进展。
Cancer Gene Ther. 2025 Jul 2. doi: 10.1038/s41417-025-00928-2.
6
Advancing therapeutics in small-cell lung cancer.小细胞肺癌治疗方法的进展
Nat Cancer. 2025 Jun 16. doi: 10.1038/s43018-025-00996-1.
7
RNF20 links the DNA damage response and metabolic rewiring in lung cancer through HIF1α.RNF20通过HIF1α将肺癌中的DNA损伤反应与代谢重编程联系起来。
Nat Commun. 2025 May 28;16(1):4929. doi: 10.1038/s41467-025-60223-4.
8
Tumor suppressors in Sox2-mediated lung cancers promote distinct cell-intrinsic and immunologic remodeling.Sox2介导的肺癌中的肿瘤抑制因子促进不同的细胞内在和免疫重塑。
JCI Insight. 2025 May 6;10(12). doi: 10.1172/jci.insight.171364. eCollection 2025 Jun 23.
9
A tumor necrosis factor-α-responsive cryptic promoter drives overexpression of the human endogenous retrovirus ERVK-7.肿瘤坏死因子-α反应性隐蔽启动子驱动人类内源性逆转录病毒ERVK-7的过表达。
J Biol Chem. 2025 Apr 30;301(6):108568. doi: 10.1016/j.jbc.2025.108568.
10
Aberrant basal cell clonal dynamics shape early lung carcinogenesis.异常的基底细胞克隆动力学塑造早期肺癌发生过程。
Science. 2025 Jun 12;388(6752):eads9145. doi: 10.1126/science.ads9145.
FGFR1 致癌激活揭示了 Rb1/p53 小鼠中 SCLC 的另一种细胞起源。
Cell Rep. 2020 Mar 17;30(11):3837-3850.e3. doi: 10.1016/j.celrep.2020.02.052.
4
Regenerative lineages and immune-mediated pruning in lung cancer metastasis.肺癌转移中的再生谱系和免疫介导的修剪。
Nat Med. 2020 Feb;26(2):259-269. doi: 10.1038/s41591-019-0750-6. Epub 2020 Feb 10.
5
CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer.CRISPR 介导的小细胞肺癌候选肿瘤抑制基因建模和功能验证。
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):513-521. doi: 10.1073/pnas.1821893117. Epub 2019 Dec 23.
6
Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes.4 种肿瘤抑制基因失活后大细胞神经内分泌癌或小细胞肺癌的差异发展。
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22300-22306. doi: 10.1073/pnas.1821745116. Epub 2019 Oct 14.
7
Rare Pulmonary Neuroendocrine Cells Are Stem Cells Regulated by Rb, p53, and Notch.罕见的肺神经内分泌细胞是由 Rb、p53 和 Notch 调控的干细胞。
Cell. 2019 Oct 3;179(2):403-416.e23. doi: 10.1016/j.cell.2019.09.010.
8
Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential.免疫检查点抑制剂在小细胞肺癌中的应用:部分实现的潜力。
Adv Ther. 2019 Aug;36(8):1826-1832. doi: 10.1007/s12325-019-01008-2. Epub 2019 Jun 17.
9
Lung Cancer Worldwide.全球肺癌情况
J Thorac Oncol. 2019 Jun;14(6):956. doi: 10.1016/j.jtho.2019.04.001.
10
Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging.通过大规模单细胞分辨率 3D 成像揭示乳腺肿瘤中的克隆内可塑性。
Cancer Cell. 2019 Apr 15;35(4):618-632.e6. doi: 10.1016/j.ccell.2019.02.010. Epub 2019 Mar 28.